AP

Alagesan Porkodi

Active Director Director DIN 09156635
DIN 09156635 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Alagesan Porkodi

Data last updated:

Alagesan Porkodi is a Director at 5H Lifexpression Private Limited (since 2021). The company operates in Healthcare. 5H Lifexpression Private Limited reported revenue of ₹49.2 Lakh (FY 2025).

DIN 09156635
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 2021
Oldest Company Age 9 yrs
Largest company 5H Lifexpression Private Limited · ₹49.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
5H Lifexpression Private Limited U74110TN2017PTC117926
Director20 Apr 20212017₹49.2 Lakh (FY 2025)Active

Board colleagues of Alagesan Porkodi

Directorship timeline

Open interactive timeline →
5H Lifexpression Private Limited
Premium access

Shareholding and investment profile for Alagesan Porkodi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alagesan Porkodi

Alagesan Porkodi currently holds 1 directorship: 5H Lifexpression Private Limited (Director, since 20 Apr 2021, revenue ₹49.2 Lakh (FY 2025)).

Alagesan Porkodi was first appointed on 20 Apr 2021 as Director at 5H Lifexpression Private Limited.

The current boards of Alagesan Porkodi's companies include Thiruvenkadam Shanmugam Sureshkumar (5H Lifexpression Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available